FDA Inspection 894213 — American Blood Bank Corp.

American Blood Bank Corp. — FEI 3007651216

The FDA completed an inspection of American Blood Bank Corp. on September 26, 2014 in Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 26, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Miami, FL (United States)

Citations

IDCFRDescription
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
926621 CFR 610.40(e)Further testing
9421 CFR 606.100(b)(15)Schedules and procedures for equipment & calibration